You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (33) |
Back to Search
The role of pharmacist in therapy optimization among patients after myocardial infarction–a preliminary study
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-PPR-020
- By: CZEPIELEWSKA, Edyta (Poland)
- Co-author(s): Edyta Czepielewska: Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Warsaw, Warsaw, Poland
Agnieszka Lisowska: Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Warsaw, Warsaw, Poland
Anna Dworakowska: Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Warsaw, Warsaw, Poland
Jadwiga Bukita: Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Warsaw, Warsaw, Poland
Joanna Marciniuk: Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Warsaw, Warsaw, Poland
Joanna Oberska: Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Warsaw, Warsaw, Poland
Adrianna Osiak: Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Warsaw, Warsaw, Poland
Liliana Pałczyńska: Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Warsaw, Warsaw, Poland
Agnieszka Serafin: 1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland
Magdalena Makarewicz-Wujec: Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Warsaw, Warsaw, Poland
Małgorzata Kozłowska-Wojciechowska: Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Warsaw, Warsaw, Poland - Abstract:
Background
Myocardial infarction (MI) is one of the leading causes of mortality in Europe. To reduce the risk of cardiovascular complications, the guidelines on management in acute coronary syndrome recommend polypharmacotherapy. Patients with MI often suffer from concomitant diseases that also require treatment. The use of multiple drugs
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026